These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Incidence, determinants and consequences of delirium in older patients after transcatheter aortic valve implantation. Goudzwaard JA; de Ronde-Tillmans MJAG; de Jager TAJ; Lenzen MJ; Nuis RJ; van Mieghem NM; Daemen J; de Jaegere PPT; Mattace-Raso FUS Age Ageing; 2020 Apr; 49(3):389-394. PubMed ID: 32091096 [TBL] [Abstract][Full Text] [Related]
28. Health-related quality-of-life after transapical transcatheter aortic valve implantation. Rex CE; Heiberg J; Klaaborg KE; Hjortdal VE Scand Cardiovasc J; 2016; 50(5-6):377-382. PubMed ID: 27615712 [TBL] [Abstract][Full Text] [Related]
29. Frailty in patients with aortic stenosis awaiting intervention. Ha FJ; Bissland K; Mandrawa C; Palmer SC Intern Med J; 2021 Mar; 51(3):319-326. PubMed ID: 31908088 [TBL] [Abstract][Full Text] [Related]
30. Prognostic Impact of Prefrailty and Frailty in Women Undergoing TAVR: Insights From the WIN-TAVI Registry. Petrovic M; Spirito A; Sartori S; Vogel B; Tchetche D; Petronio AS; Mehilli J; Lefevre T; Presbitero P; Capranzano P; Pileggi B; Iadanza A; Sardella G; van Mieghem NM; Meliga E; Feng Y; Dumonteil N; Cohen R; Fraccaro C; Trabattoni D; Mikhail G; Ferrer-Gracia MC; Naber C; Sharma SK; Watanabe Y; Morice MC; Dangas GD; Chieffo A; Mehran R Can J Cardiol; 2024 Mar; 40(3):457-467. PubMed ID: 37923124 [TBL] [Abstract][Full Text] [Related]
31. Effect of diabetes mellitus on clinical outcomes and quality of life after transcatheter aortic valve implantation for severe aortic valve stenosis. Tokarek T; Dziewierz A; Wiktorowicz A; Bagienski M; Rzeszutko L; Sorysz D; Kleczynski P; Dudek D Hellenic J Cardiol; 2018; 59(2):100-107. PubMed ID: 28807801 [TBL] [Abstract][Full Text] [Related]
32. Gait Speed Can Predict Advanced Clinical Outcomes in Patients Who Undergo Transcatheter Aortic Valve Replacement: Insights From a Japanese Multicenter Registry. Kano S; Yamamoto M; Shimura T; Kagase A; Tsuzuki M; Kodama A; Koyama Y; Kobayashi T; Shibata K; Tada N; Naganuma T; Araki M; Yamanaka F; Shirai S; Mizutani K; Tabata M; Ueno H; Takagi K; Higashimori A; Otsuka T; Watanabe Y; Hayashida K Circ Cardiovasc Interv; 2017 Sep; 10(9):. PubMed ID: 28916601 [TBL] [Abstract][Full Text] [Related]
33. Serial change in health-related quality of life over 1 year after transcatheter aortic valve implantation: predictors of health outcomes. Fairbairn TA; Meads DM; Mather AN; Motwani M; Pavitt S; Plein S; Blackman DJ; Greenwood JP J Am Coll Cardiol; 2012 May; 59(19):1672-80. PubMed ID: 22554597 [TBL] [Abstract][Full Text] [Related]
34. Impact of chronic obstructive pulmonary disease and frailty on long-term outcomes and quality of life after transcatheter aortic valve implantation. Dziewierz A; Tokarek T; Kleczynski P; Sorysz D; Bagienski M; Rzeszutko L; Dudek D Aging Clin Exp Res; 2018 Sep; 30(9):1033-1040. PubMed ID: 29185204 [TBL] [Abstract][Full Text] [Related]
35. Frailty is associated with chronic inflammation and pro-inflammatory monocyte subpopulations. Cybularz M; Wydra S; Berndt K; Poitz DM; Barthel P; Alkouri A; Heidrich FM; Ibrahim K; Jellinghaus S; Speiser U; Linke A; Christoph M; Pfluecke C Exp Gerontol; 2021 Jul; 149():111317. PubMed ID: 33744391 [TBL] [Abstract][Full Text] [Related]
36. Interaction Between Frailty and Access Site in Older Adults Undergoing Transcatheter Aortic Valve Replacement. Drudi LM; Ades M; Asgar A; Perrault L; Lauck S; Webb JG; Rassi A; Lamy A; Noiseux N; Peterson MD; Labinaz M; Lefèvre T; Popma JJ; Kim DH; Martucci G; Piazza N; Afilalo J JACC Cardiovasc Interv; 2018 Nov; 11(21):2185-2192. PubMed ID: 30343019 [TBL] [Abstract][Full Text] [Related]
37. Restricted mean survival time of older adults with severe aortic stenosis referred for transcatheter aortic valve replacement. Rodighiero J; Piazza N; Martucci G; Spaziano M; Lachapelle K; de Varennes B; Ouimet MC; Afilalo J BMC Cardiovasc Disord; 2020 Jun; 20(1):299. PubMed ID: 32552887 [TBL] [Abstract][Full Text] [Related]
38. Quality of life in patients with severe aortic stenosis undergoing transcatheter aortic valve implantation: tools and evidence. Metra M; Radulescu CI; Cersosimo A; Massussi M; Laurito A; Chioncel O; Adamo M J Cardiovasc Med (Hagerstown); 2024 Apr; 25(4):259-270. PubMed ID: 38488063 [TBL] [Abstract][Full Text] [Related]
39. Adiponectin serum level is an independent and incremental predictor of all-cause mortality after transcatheter aortic valve replacement. Walpot J; van Herck P; Collas V; Bossaerts L; Van de Heyning CM; Vandendriessche T; Heidbuchel H; Rodrigus I; De Block C; Small GR; Bosmans J Clin Cardiol; 2022 Oct; 45(10):1060-1069. PubMed ID: 35932173 [TBL] [Abstract][Full Text] [Related]
40. Usefulness of Psoas Muscle Area and Volume and Frailty Scoring to Predict Outcomes After Transcatheter Aortic Valve Implantation. Kleczynski P; Tokarek T; Dziewierz A; Sorysz D; Bagienski M; Rzeszutko L; Dudek D Am J Cardiol; 2018 Jul; 122(1):135-140. PubMed ID: 29703441 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]